InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: scottsmith post# 229935

Tuesday, 06/05/2018 6:56:58 AM

Tuesday, June 05, 2018 6:56:58 AM

Post# of 403079
That 7B sales prediction for prurisol is not impossible. Let's consider psoriasis alone. Global market for psoriasis drugs is probably about $12 to $14 B.

If prurisol's PASI 75 response will be around 50 % it would be likely that P would become standard of care in first line psoriasis treatment. And as a standard of care capturing something like 50 to 60 % of the market is not impossible.

But there are some obvious caveats

1. Will P get to PASI 75 response 50 % is the big time ?????????
2. There is a built-in assumption in the above pricing logic: it assumes that prurisol would be priced at current price level for psoriasis drugs, including biologics. I don't know if that kind of price is attainable or even desirable. There would be all sorts of resistance.

"There's no sense in being precise when you don't even know what you're talking about." John v. Neumann

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News